¿¬±¸µ¿ÇâÁ¤º¸
Á¦¸ñ ÃֽŠ[ÀÓ»óÀÇÇÐ] ¿¬±¸µ¿Çâ Å°¿öµå ³×Æ®¿öÅ© ºÐ¼®
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

 


 

ÃֽŠÀÇ°úÇÐ Å°¿öµå ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®

 

8¿ù [ÀÓ»óÀÇÇÐ] ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®



 



 

                        ±×¸² 1.  ÀÓ»óÀÇÇÐ 8¿ù ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå






 

ÃֽŠÀÇ°úÇÐºÐ¾ß ±¹³»¿Ü Àú³ÎÀ» ÅëÇØ ¹ßÇ¥ÇÑ ÀÓ»óÀÇÇÐ ³í¹®Àº ±¹³» 736Æí°ú ±¹Á¦ Àú³ÎÀ» ÅëÇØ 800ÆíÀÌ ¹ßÇ¥µÇ¾î ÃÑ 1,536ÆíÀÌ ¹ßÇ¥µÇ¾ú´Ù. ÀÌ´Â Àü¿ù 7¿ù¿¡ ºñ±³ÇÏ¿© 16.4% (303Æí)ÀÌ °¨¼ÒÇÑ Ãß¼¼ÀÌ´Ù. ÃֽŠÀÓ»óÀÇÇÐ ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®¿¡¼­´Â General Surgery, Neoplasms, Survival Rate,  ¹× COVID-19¸¦ Áß½ÉÀ¸·Î ÇÑ ¿¬±¸ÁÖÁ¦¸¦ Áß½ÉÀ¸·Î ¿¬±¸µ¿Çâ ÃàÀ» Çü¼ºÇÏ¿´´Ù. ´ë»óÀÚ ¼ºº°·Î´Â ¿©¼ºÀ» Áß½ÉÀ¸·Î ÇÑ ¿¬±¸°¡ È°¹ßÇÏ°Ô ÁøÇàµÇ°í ÀÖÀ½µµ ³ªÅ¸³µ´Ù(Ç¥ 1).  



 

 

                  ±×¸² 2. ±¹³» 8¿ù ÀÓ»óÀÇÇÐ ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®




 

 

                        ±×¸² 3. ±¹¿Ü 8¿ù ÀÓ»óÀÇÇÐ ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®



 

Ç¥  1.  ÀÓ»óÀÇÇÐ 8¿ù ÅäÇÈ ³×Æ®¿öÅ© ¸ðµ¨¸µ   

Topic1

Topic2

Topic3

Topic4

Topic5

Risk

Women

General Surgery

Neoplasms

COVID-19

Sensitivity And Specificity

Serum

Risk

Recurrence

Vaccination

F-18 Fdg Pet

Diabetes

Pain

Survival Rate

Depression

Complication

Sex

Pediatrics

Drug Therapy

Risk

Stroke

Bmi

Mortality

Genes

Pediatrics

Evaluation Studies As Topic

Hypertension

Complication

General Surgery

Brain

Women

Attention

Asthma

Neoplasm Metastasis

Adolescent

General Surgery

Risk

Population

Breast Neoplasms

Alzheimer Disease

Dataset

Learning

Chronic Obstructive Lung Disease

Liver

Older Adults

Bone & Bones

Balance

Risk Factors

Risk

Women

 




 

 

                    

                     ±×¸² 4.  8¿ù ÀÓ»óÀÇÇÐ ÅäÇÈ Å°¿öµå ³×Æ®¿öÅ© ¿¬±¸µ¿Ç⠺м® 





 

Ç¥  2.   8¿ù ÀÓ»óÀÇÇÐ ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå (n=1,536)

 

Å°¿öµå ¼øÀ§

±¹³» ÀÓ»óÀÇÇÐ Å°¿öµå

±¹¿Ü ÀÓ»óÀÇÇÐ Å°¿öµå

ÅëÇÕ ÀÓ»óÀÇÇÐ Å°¿öµå 

1

Risk

Risk

Risk

2

General Surgery

General Surgery

General Surgery

3

Women

Neoplasms

Women

4

Pediatrics

Survival Rate

Neoplasms

5

Complication

Women

Survival Rate

6

COVID-19

COVID-19

COVID-19

7

Neoplasms

Brain

Complication

8

Drug

Mortality

Pediatrics

9

Recurrence

Recurrence

Recurrence

10

Pain

Pain

Mortality

 

Survival Rate

   







 

8¿ù¿¡ ¹ßÇ¥µÈ ±¹³»¿Ü ÀÇ°úÇÐºÐ¾ß ³í¹® ¹ßÇ¥ Áß¿¡¼­ ÀÓ»óÀÇÇÐ³í¹®ÀÌ Â÷ÁöÇÏ´Â ºñÀ²Àº Àüü¿¡¼­ 46.7%¸¦ Â÷ÁöÇÏ¿© Àü¿ù 50.2%¿¡ ºñ±³ÇÏ¿© ¾à°£ °¨¼ÒÇÑ Ãß¼¼¸¦ ³ªÅ¸³»¾úÀ¸³ª, ÀÇ°úÇÐºÐ¾ß Áß¿¡¼­ ÀÓ»óÀÇÇÐÀÌ Â÷ÁöÇÏ´Â ºñÀ²Àº Áö¼ÓÀûÀ¸·Î °¡Àå ³ôÀº ¼øÀ§¸¦ ³ªÅ¸³»¾ú´Ù.  ÃֽŠÀÓ»óÀÇÇÐ ¿¬±¸µ¿Ç⠺м®¿¡ »ç¿ëµÈ ³í¹® µ¥ÀÌÅÍ´Â ±¹³» Àú³Î°ú ÇØ¿Ü Àú³ÎÀ» ÅëÇØ  ¹ßÇ¥µÈ ³í¹® Áß¿¡¼­ Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase)¿Í ¹Ì±¹ ±¹¸³º¸°Ç¿ø(NIH)ÀÇ Æà¸Þµå(PubMed) MEDLINE µ¥ÀÌÅͺ£À̽º¿¡¼­ ³í¹®ÀڷḦ ÃßÃâÇÏ¿© ºÐ¼®ÇÏ¿´´Ù. 









 

      ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC) Á¦°ø





 

* º» ³»¿ëÀº MedRIC (www.medric.or.kr)ÀÇ ¿¬±¸µ¿Çâ¿¡¼­ Á¦°øµÇ´Â ³»¿ëÀÔ´Ï´Ù.




 


2022-09-22 ¿ÀÀü 11:27:38, Á¶È¸¼ö : 521